| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.43 | 0.009 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.43 | 0.009 |